VAERS reports by lot

GSK DTaP/Tdap lot G9N2M: VAERS reports

77 VAERS reports list lot G9N2M as a GSK DTaP/Tdap vaccine, received between 2022-11-03 and 2024-07-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
77
Reports
0%
Marked serious
0
With a death outcome
20
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction1173%
Neurological17%
Gastrointestinal17%
Psychiatric / Neuropsychiatric17%
General / Systemic (non-local)17%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan14
Washington12
Wisconsin5
Missouri5
Idaho5
California3
Maryland3
New Hampshire2
Pennsylvania2
Ohio2
Indiana2
North Carolina2

Reports by month received

2022-114
2022-124
2023-013
2023-026
2023-036
2023-0410
2023-055
2023-066
2023-074
2023-083
2023-092
2023-105
2023-114
2024-011
2024-022
2024-032
2024-046
2024-052
2024-061
2024-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.